Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by BNC Wealth Management LLC

BNC Wealth Management LLC raised its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 5.7% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 11,148 shares of the medical equipment provider's stock after purchasing an additional 603 shares during the period. Intuitive Surgical accounts for approximately 1.9% of BNC Wealth Management LLC's portfolio, making the stock its 15th largest holding. BNC Wealth Management LLC's holdings in Intuitive Surgical were worth $5,819,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently modified their holdings of the company. Godsey & Gibb Inc. increased its position in Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after purchasing an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. acquired a new position in Intuitive Surgical during the third quarter worth approximately $33,000. Decker Retirement Planning Inc. acquired a new position in Intuitive Surgical during the fourth quarter worth approximately $36,000. Capital Performance Advisors LLP acquired a new position in Intuitive Surgical during the third quarter worth approximately $38,000. Finally, DT Investment Partners LLC increased its position in shares of Intuitive Surgical by 80.0% in the third quarter. DT Investment Partners LLC now owns 81 shares of the medical equipment provider's stock worth $40,000 after acquiring an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Stock Up 1.5 %

Shares of NASDAQ:ISRG traded up $8.56 on Friday, reaching $592.64. 2,630,118 shares of the company's stock were exchanged, compared to its average volume of 1,158,623. The firm has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a fifty-two week low of $362.14 and a fifty-two week high of $597.68. The business's 50-day moving average is $540.66 and its two-hundred day moving average is $499.19.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The company had revenue of $2.04 billion for the quarter, compared to analysts' expectations of $2.01 billion. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. Analysts predict that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP Brian Edward Miller sold 2,553 shares of the stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the sale, the executive vice president now owns 7,066 shares of the company's stock, valued at $3,638,990. This trade represents a 26.54 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction dated Friday, November 8th. The stock was sold at an average price of $525.00, for a total transaction of $12,024,075.00. Following the completion of the sale, the insider now directly owns 8,757 shares in the company, valued at approximately $4,597,425. This trade represents a 72.34 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 48,190 shares of company stock valued at $25,012,927. Company insiders own 0.80% of the company's stock.

Analyst Ratings Changes

Several equities research analysts have recently issued reports on the stock. Oppenheimer reissued a "market perform" rating on shares of Intuitive Surgical in a research report on Friday, October 18th. Morgan Stanley raised shares of Intuitive Surgical from an "equal weight" rating to an "overweight" rating and increased their price objective for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Citigroup increased their price objective on shares of Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a research report on Wednesday, December 11th. The Goldman Sachs Group set a $604.00 price objective on shares of Intuitive Surgical in a research report on Friday, October 18th. Finally, Robert W. Baird increased their price objective on shares of Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have assigned a buy rating to the company. According to MarketBeat, Intuitive Surgical currently has a consensus rating of "Moderate Buy" and an average target price of $554.17.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.